International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
Antiviral Activity of Synthetic Bis-Naphthoquinone (H-5) Against Chikungunya Virus Replication
| Author(s) | Ms. Lavanya HN, Ms. Pravalika KM, Dr. sunil kumar busi, Dr. Gopinatha Elumalai |
|---|---|
| Country | India |
| Abstract | Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that has emerged as a major global public health concern due to its rapid spread and the absence of specific antiviral therapies. Infection with CHIKV commonly causes high fever, severe polyarthralgia, myalgia, headache, and skin rash, with joint pain often persisting for months or years, significantly affecting the quality of life of infected individuals. Although supportive care remains the primary treatment option, the growing burden of chikungunya has emphasized the need for the development of safe and effective antiviral agents. Among various compounds investigated, naphthoquinone derivatives have attracted considerable attention because of their broad-spectrum biological activities, including antiviral, antibacterial, antifungal, antiparasitic, anticancer, and anti-inflammatory properties. Synthetic bis-naphthoquinone (H-5) has recently emerged as a promising antiviral candidate against CHIKV. Experimental studies have demonstrated that H-5 effectively inhibits viral replication in infected cells while exhibiting comparatively low cytotoxicity toward host cells. In addition, preclinical investigations suggest that H-5 can reduce viral load and improve disease outcomes in animal models. The antiviral effect of H-5 is believed to result from interference with critical stages of the viral replication cycle, making it a potential lead molecule for the development of novel anti-chikungunya therapeutics. Furthermore, studies have reported enhanced antiviral activity when H-5 is used in combination with ribavirin, indicating the possibility of combination therapy for improved clinical efficacy. |
| Keywords | Chikungunya Virus, Synthetic Bis-Naphthoquinone, H-5, Antiviral Activity, Viral Replication, Naphthoquinone Derivatives |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 4, July-August 2026 |
| Published On | 2026-08-12 |
| DOI | https://doi.org/10.36948/ijfmr.2026.v08i04.85628 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals